Navigation Links
World Neurostimulation Market to Reach $5.2 Billion by 2012, According to New Report by Global Industry Analysts
Date:11/3/2008

Driven by technology advancements, rising consumer awareness, and development of sophisticated implantable neurostimulation devices, world market for neurostimulation is projected to reach $5.2 billion by the year 2012. Conducive demographics like the aging world population offers ample opportunities for growth in the upcoming years. Emergence of new indications for the use of the neurostimulation therapy is expected to result in expanded market opportunities.

San Jose, CA (PRWEB) November 3, 2008 -- The world neurostimulation market stands enthused by the growing base of aging population, and the resultant rise in age-related diseases such as, Parkinson's, and Alzheimer's disease. Widespread prevalence of neurological disorders and conditions, and the associated costs to society in terms of declining productivity, and reduced quality of life, offer a business case for the neurostimulation treatment modality. Demand for a higher quality of life, rising awareness among both physicians and patients, and improved patient outcomes are together, helping drive growth in the market. Influx of new players is giving rise to increased investments and research and developments. This is expected to lead to a spurt in technology innovations, and development of novel, advanced products, such as closed-loop system neurostimulators, which are designed to continuously stimulate the nervous system. As stated by the recent report published by Global Industry Analysts, Inc., the United States ranks as the single largest market for neurostimulation worldwide, more than 75% share estimated in the year 2008. Innovations in the field of brain imaging, interactive computer guidance devices, and single cell microelectrode recordings, are all helping drive the effectiveness, and hence growth of neurostimulation. With public and private health insurance companies mulling reimbursements for neurostimulation procedures and devices, the market stands to gain attractively in the medium to long run.        

Guided by strong research and development agendas, growth in US market is projected at a CAGR of about 17% for the period 2007 through 2012. In the world spinal cord stimulators market, strong growth is expected to stem from implantable pulse generator (IPG) segment, which is expected to reach US $2.17 billion by 2012. World market for vagus nerve stimulators is projected to grow at a projected CAGR of 22.17% over the period 2007 to 2012. In the United States, revenues in the deep brain stimulators market are projected to rise by US$607.8 million over the period 2007 to 2012.

Leading global and regional players operating in the industry include Boston Scientific Corp, St. Jude Medical Inc, Cyberonics Inc, Medtronic Inc, Afferent Corp, Cyberkinetics Neurotechnology Systems Inc, Northstar Neuroscience Inc, and Synapse Biomedical Inc, among others.

The report titled "Neurostimulation: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of the market trends, drivers, issues, and challenges. Richly annotated with authoritative, and unbiased commentaries, and hard-to-find statistical facts, the report provides unequivocal views on future potential while throwing light on the prevailing climate in key product markets. Product markets analyzed in the report include Spinal Cord Stimulators (SCS) (Radio Frequency (RF) System, and Implantable Pulse Generator (IPG)), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES). Latent demand patterns in product markets are quantified across the United States, and Rest of World. Also provided in the report is an enumeration of recent mergers, acquisitions, and other strategic industry activities.

For more details about this research report, please visit http://www.strategyr.com/Neurostimulation_Market_Report.asp.

About Global Industry Analysts, Inc.:
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/neurostimulation/spinal_cord_stimulators/prweb1553484.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. HTH Worldwide Ranked Number 21 in Deloittes Fast 50 Program for Greater Philadelphia
2. HealthWorldNet.com Receives Three Excellence Awards
3. Esteemed Emergency Medicine Physician Appointed to TeleHealth World Magazine Editorial Advisory Board
4. World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
5. Repair and healing of osteoporotic fractures a focus of upcoming IOF World Congress on Osteoporosis
6. Considering Revision Surgery? Board Certified Plastic Surgeon and Washington DC-based Dr. Mark E. Richards Pioneers Facelift Revisions Attracting Patients Worldwide
7. WorldHeart Announces Effectiveness of Reverse Stock Split
8. Our cheatin brain: The brains clever way of showing us the world as a whole
9. Several US Children Among Worldwide Heroes for Inspirational Fundraising Efforts with Celine Dion
10. World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc.
11. University Of Minnesota Gives 11,538 Flu Shots Tuesday, Shattering Guinness World Record for Most Flu Shots in a Single Day
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Neurostimulation Market to Reach $5.2 Billion by 2012, According to New Report by Global Industry Analysts
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: